SutherlandJGlueekHIGleserG. Haemorrhagic disease of the newborn — breast feeding as a necessary factor in the pathogenesis. Am J Dis Child1967; 113: 524–532
3.
LehmannJ. Vitamin K as prophylaxis in thirteen thousand infants. Lancet1944; 1: 493–495
4.
WhitfieldMFSalfieldSAW. Accidental administration of Syntometrine in adult dosage to the newborn. Arch Dis Child1980; 55: 68–70
5.
McNinchAWL'E OrmeRTrippJH. Haemorrhagic disease of the newborn returns. Lancet. 1983; 1: 1089–1090
6.
TrippJHMcNinchAW. Haemorrhagic disease and vitamin K. Arch Dis Child1987; 62: 436–437
7.
McNinchAWTrippJH. Haemorrhagic disease of the newborn in the British Isles. Two year prospective study. BMJ. 1991; 303: 1105–1109
8.
HandelJTrippJH. Vitamin K prophylaxis against haemorrhagic disease of the newborn in the United Kingdom. BMJ1991; 303: 1109
9.
GoldingJGreenwoodRBirminghamKMottM. Childhood cancer, intramuscular vitamin K and pethidine given during labour. BMJ1992; 305: 341–346
10.
MerensteinGBHathawayWEMillerRWPaulsonJARowleyDL. Controversies concerning vitamin K and the newborn. Pediatrics1993; 91: 1001–1002
11.
FrommerMMurphyEChurchesTHenderson-SmartD. Vitamin K prophylaxis in newborn infants. New South Wales Public Health Bulletin1993; 4: 13–17
12.
DraperGJStillerCA. Intramuscular vitamin K and childhood cancer. BMJ1992; 305: 709
13.
EkelundHFinnstromOGunnarskogJKallenBLarssonY. Administration of vitamin K to newborn infants and childhood cancer. BMJ1993; 307: 89–91
14.
KlebanoffMAReadJSMillsJLShionoPH. The risk of childhood cancer after neonatal exposure to Vitamin K. N Engl J Med1993; 329: 905–908
15.
von KriesRGobelUHachmeisterAKaletshUMichaelisJ. Vitamin K, childhood cancer. A population based case control study in Lower Saxony, Germany. BMJ1996; 313: 199–203
16.
AnsellPBullDRomanE. Childhood leukaemia and intramuscular vitamin K. Findings from a case control study. BMJ1996; 313: 204–205
17.
ZipurskyA. Vitamin K at birth. BMJ1996; 313: 179–180
18.
ClarkFJamesE. Thirty seven years experience of oral vitamin K therapy in neonates. J Pediatr1995; 127: 301–304
19.
von KriesRHachmeisterAGobelU. Repeated oral vitamin K prophylaxis in West Germany. Acceptance and efficacy. BMJ1995; 310: 1097–1098
20.
ClarksonPJamesA. Parenteral vitamin K1. The effective prophylaxis against haemorrhagic disease for all newborn infants. N Z Med J1990; 103: 95–96
21.
RennieJKelsallW. Vitamin K prophylaxis in the newborn — again. Arch Dis Child. 1994; 70: 248–251
22.
British Paediatric Association. Vitamin K prophylaxis in infancy. 27 Nov 1992
23.
Chief Medical Officer Advice. Prophylaxis Against Vitamin K Deficiency Bleeding in Infants. December 1992; PL/CMO (92) 20
24.
Vitamin K supplements in the newborn. Drug Ther Bull1993; 31: 79–80
25.
Vitamin K ad hoc task force. American Academy of Pediatrics. Controversies concerning vitamin K in the newborn. Pediatrics1993; 91: 1001–1003
26.
Joint statement and interim recommendations on vitamin K prophylaxis for haemorrhagic disease in infancy. J Paediatr Child Health1993; 29: 182
27.
Amedee-ManesmeOLambertWAlagilleTDe LeenheerA. Pharmacokinetics and safety of a new solution of vitamin K1 in children with cholestasis. J Pediatr Gastroenterol Nutr1992; 14: 160–165
28.
IsarangkuraPShearerMJPintdittP. Vitamin K (Konakion MM) by oral route in the prevention of the haemorrhagic disease of the newborn and idiopathic vitamin K deficiency in infants. International Symposium, Basel, Switzerland, October, 1994
29.
BartonJSTrippJHMcNinchAW. Neonatal vitamin K prophylaxis in the British Isles: current practice and trends. BMJ1995; 310: 632–633
30.
SlatteryJM. Why we need a clinical trial for vitamin K. BMJ1994; 308: 908–910
31.
CroucherCAzzobardiD. Compliance with recommendations for giving Vitamin K to newborn infants. BMJ1994; 308: 894–895
32.
HodgsonH. Vitamin K. Friend or foe. Nursing Times Midwife1996; 92: 60